91 related articles for article (PubMed ID: 15535738)
61. Integrated autofluorescence characterization of a modified-diet liver model with accumulation of lipids and oxidative stress.
Croce AC; Ferrigno A; Piccolini VM; Tarantola E; Boncompagni E; Bertone V; Milanesi G; Freitas I; Vairetti M; Bottiroli G
Biomed Res Int; 2014; 2014():803491. PubMed ID: 25006587
[TBL] [Abstract][Full Text] [Related]
62. Enhanced visibility of colonic neoplasms using formulaic ratio imaging of native fluorescence.
Banerjee B; Rial NS; Renkoski T; Graves LR; Reid SA; Hu C; Tsikitis VL; Nfonsom V; Pugh J; Utzinger U
Lasers Surg Med; 2013 Nov; 45(9):573-81. PubMed ID: 24114774
[TBL] [Abstract][Full Text] [Related]
63. In vivo imaging of cerebral energy metabolism with two-photon fluorescence lifetime microscopy of NADH.
Yaseen MA; Sakadžić S; Wu W; Becker W; Kasischke KA; Boas DA
Biomed Opt Express; 2013 Feb; 4(2):307-21. PubMed ID: 23412419
[TBL] [Abstract][Full Text] [Related]
64. Ratio images and ultraviolet C excitation in autofluorescence imaging of neoplasms of the human colon.
Renkoski TE; Banerjee B; Graves LR; Rial NS; Reid SA; Tsikitis VL; Nfonsam VN; Tiwari P; Gavini H; Utzinger U
J Biomed Opt; 2013 Jan; 18(1):16005. PubMed ID: 23291657
[TBL] [Abstract][Full Text] [Related]
65. Antibiotic transport in resistant bacteria: synchrotron UV fluorescence microscopy to determine antibiotic accumulation with single cell resolution.
Kaščáková S; Maigre L; Chevalier J; Réfrégiers M; Pagès JM
PLoS One; 2012; 7(6):e38624. PubMed ID: 22719907
[TBL] [Abstract][Full Text] [Related]
66. Optical imaging of metabolism in HER2 overexpressing breast cancer cells.
Walsh A; Cook RS; Rexer B; Arteaga CL; Skala MC
Biomed Opt Express; 2012 Jan; 3(1):75-85. PubMed ID: 22254170
[TBL] [Abstract][Full Text] [Related]
67. Assessment of cell viability in three-dimensional scaffolds using cellular auto-fluorescence.
Dittmar R; Potier E; van Zandvoort M; Ito K
Tissue Eng Part C Methods; 2012 Mar; 18(3):198-204. PubMed ID: 21981657
[TBL] [Abstract][Full Text] [Related]
68. Automated biochemical, morphological, and organizational assessment of precancerous changes from endogenous two-photon fluorescence images.
Levitt JM; McLaughlin-Drubin ME; Münger K; Georgakoudi I
PLoS One; 2011; 6(9):e24765. PubMed ID: 21931846
[TBL] [Abstract][Full Text] [Related]
69. Optical redox ratio differentiates breast cancer cell lines based on estrogen receptor status.
Ostrander JH; McMahon CM; Lem S; Millon SR; Brown JQ; Seewaldt VL; Ramanujam N
Cancer Res; 2010 Jun; 70(11):4759-66. PubMed ID: 20460512
[TBL] [Abstract][Full Text] [Related]
70. Two-photon microscopy for non-invasive, quantitative monitoring of stem cell differentiation.
Rice WL; Kaplan DL; Georgakoudi I
PLoS One; 2010 Apr; 5(4):e10075. PubMed ID: 20419124
[TBL] [Abstract][Full Text] [Related]
71. Intracellular coenzymes as natural biomarkers for metabolic activities and mitochondrial anomalies.
Heikal AA
Biomark Med; 2010 Apr; 4(2):241-63. PubMed ID: 20406068
[TBL] [Abstract][Full Text] [Related]
72. Nonlinear optical imaging of cellular processes in breast cancer.
Provenzano PP; Eliceiri KW; Yan L; Ada-Nguema A; Conklin MW; Inman DR; Keely PJ
Microsc Microanal; 2008 Dec; 14(6):532-48. PubMed ID: 18986607
[TBL] [Abstract][Full Text] [Related]
73. Multiphoton microscopy and fluorescence lifetime imaging microscopy (FLIM) to monitor metastasis and the tumor microenvironment.
Provenzano PP; Eliceiri KW; Keely PJ
Clin Exp Metastasis; 2009; 26(4):357-70. PubMed ID: 18766302
[TBL] [Abstract][Full Text] [Related]
74. Adaptation and response of Bifidobacterium animalis subsp. lactis to bile: a proteomic and physiological approach.
Sánchez B; Champomier-Vergès MC; Stuer-Lauridsen B; Ruas-Madiedo P; Anglade P; Baraige F; de los Reyes-Gavilán CG; Johansen E; Zagorec M; Margolles A
Appl Environ Microbiol; 2007 Nov; 73(21):6757-67. PubMed ID: 17827318
[TBL] [Abstract][Full Text] [Related]
75. Low-pH adaptation and the acid tolerance response of Bifidobacterium longum biotype longum.
Sánchez B; Champomier-Vergès MC; Collado Mdel C; Anglade P; Baraige F; Sanz Y; de los Reyes-Gavilán CG; Margolles A; Zagorec M
Appl Environ Microbiol; 2007 Oct; 73(20):6450-9. PubMed ID: 17720838
[TBL] [Abstract][Full Text] [Related]
76. Cactus pear: a natural product in cancer chemoprevention.
Zou DM; Brewer M; Garcia F; Feugang JM; Wang J; Zang R; Liu H; Zou C
Nutr J; 2005 Sep; 4():25. PubMed ID: 16150152
[TBL] [Abstract][Full Text] [Related]
77. Endogenous fluorescence spectroscopy of cell suspensions for chemopreventive drug monitoring.
Kirkpatrick ND; Zou C; Brewer MA; Brands WR; Drezek RA; Utzinger U
Photochem Photobiol; 2005; 81(1):125-34. PubMed ID: 15535738
[TBL] [Abstract][Full Text] [Related]
78. Antitumor activity of 4-(N-hydroxyphenyl)retinamide conjugated with poly(L-glutamic acid) against ovarian cancer xenografts.
Zou C; Brewer M; Cao X; Zang R; Lin J; Deng Y; Li C
Gynecol Oncol; 2007 Dec; 107(3):441-9. PubMed ID: 17854871
[TBL] [Abstract][Full Text] [Related]
79. Fluorescence spectroscopy as a biomarker in a cell culture and in a nonhuman primate model for ovarian cancer chemopreventive agents.
Brewer M; Utzinger U; Li Y; Atkinson EN; Satterfield W; Auersperg N; Richards-Kortum R; Follen M; Bast R
J Biomed Opt; 2002 Jan; 7(1):20-6. PubMed ID: 11818008
[TBL] [Abstract][Full Text] [Related]
80. Biomarker modulation in a nonhuman rhesus primate model for ovarian cancer chemoprevention.
Brewer M; Utzinger U; Satterfield W; Hill L; Gershenson D; Bast R; Wharton JT; Richards-Kortum R; Follen M
Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):889-93. PubMed ID: 11489756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
